HCV inhibitors
US7608592B2 · kind B2 · utility
1Cited by
8References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2006 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Jun 28, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.